Emmaus Life Sciences, Inc. Share Price Other OTC
Equities
EMMA
US29137T1016
Biotechnology & Medical Research
Sales 2021 | 20.61M 1.65B | Sales 2022 | 18.39M 1.47B | Capitalization | 12.9M 1.03B |
---|---|---|---|---|---|
Net income 2021 | -15M -1.2B | Net income 2022 | -10M -801M | EV / Sales 2021 | 4.97 x |
Net Debt 2021 | 20.13M 1.61B | Net Debt 2022 | 28.8M 2.31B | EV / Sales 2022 | 2.27 x |
P/E ratio 2021 |
-5.16
x | P/E ratio 2022 |
-1.21
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 48.23% |
Managers | Title | Age | Since |
---|---|---|---|
George Sekulich
PSD | President | 59 | 30/04/19 |
Willis Lee
CHM | Chairman | 64 | 16/07/19 |
Yasushi Nagasaki
DFI | Director of Finance/CFO | 57 | 30/04/11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Wei Peu Zen
BRD | Director/Board Member | 71 | 16/07/19 |
Willis Lee
CHM | Chairman | 64 | 16/07/19 |
Ian Zwicker
BRD | Director/Board Member | 77 | 16/07/19 |
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |